leisure time -WSS

leisure time

author：knowledge 2025-09-28 02:31:20 - browse：5

Nathan Guo, left, and his wife Ada Lio encourage their 17-month-old son, Lucas Guo, to take steps in his gate trainer at their home in Somerville, MA on February 16, 2024. Lucas has one of the world's rarest diseases, ZTTK Syndrome — Lucas Guo, a boy with a rare neurological condition called ZTTK, is encouraged by his father, Nathan Guo, and mother, Ada Lio, to take some steps. Craig F. Walker/The Boston Globe

SOMERVILLE — At 19 months old, Lucas Guo has never crawled, walked, or stood by himself. He babbles but can’t say words. He struggles to chew and swallow. He gets most of his nutrition through a feeding tube attached to his belly.

Lucas has one of the world’s rarest diseases, ZTTK syndrome, a complex neurological disorder caused by a genetic mutation. Scientists have documented only about 60 cases worldwide and estimate that, at most, it afflicts several hundred people — far too few to encourage drug makers to find a treatment.

That economic reality has driven Lucas’s parents, Ada Lio and Nathan Guo, to take things into their own hands. Working through a small foundation, they are trying to raise $10 million to develop a treatment or cure for ZTTK in five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Ibogaine psychedelic therapy for opioid addiction unlikely, official says

WSS

Chinese researcher claims birth of first gene

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Erich Jarvis studies song birds to learn about human stuttering

Yancopoulos of Regeneron works to expand Dupixent success

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

U.K. officials, researchers try to ease path for bespoke genetic treatments

focus

leisure time

explore

Virginia high school admissions case could be legal follow

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Sage considers ways to reduce costs following FDA rejection

The high cost of giving birth even with insurance

Pregnancy ages women, but effects reverse after delivery

Guidelines to prevent youth baseball injuries need more muscle

'Patient friction coefficient' can gauge a clinical trial's patient burden

Trump demands the U.S. pay no more for drugs than other countries … again

Feed a cold, starve a fever? Here’s what science says

hotspot

This gene therapy has record $4.25 million price. It's saved children.

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Feed a cold, starve a fever? Here’s what science says

focus

focus

Wikipedia

entertainment